Imago BioSciences Inc

NASDAQ:IMGO  
14.03
+0.37 (+2.71%)
Earnings Announcements

Imago Biosciences Reports Fourth Quarter And Full Year 2021 Financial Results

Published: 03/24/2022 20:54 GMT
Imago BioSciences Inc (IMGO) - Imago Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results.
Imago Biosciences Inc - Qtrly Net Loss per Share, Basic and Diluted $0.44.
Imago Biosciences Inc- As of December 31, 2021, Imago Had Cash, Cash Equivalents, Restricted Cash and Short-term Investments of $217.4 Million.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.48

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.50

More details on our Analysts Page.